Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors – PRRT vs Everolimus December 21, 2020 Read More »
Clinical Trial: Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors (TALENT) October 1, 2020 Read More »
Sapanisertib – a drug on trial for Neuroendocrine Tumors (NET) with a pancreatic primary May 8, 2019 Read More »
Phase 3 Clinical Trial of 177Lu-Edotreotide (Solucin®) – COMPETE for GEPNETs December 22, 2020 Read More »
Recent Progress in NET Management – Positive presentation from Jonathan R Strosberg MD February 21, 2017 Read More »
Neuroendocrine Tumor Drug Clinical Trial – Cabozantinib (includes news on Pheochromoctyoma and Paraganglioma) November 27, 2020 Read More »
Clinical Trial: Neuroendocrine Cancer drug in the pipeline – Fosbretabulin Tromethamine CA4P (incl combo with Everolimus) June 4, 2019 Read More »
